JP Patent

JP7051693B2 — ＰＩＫ３ＣＡ関連過成長症候群（ＰＲＯＳ ＣＬＯＶａＳ症候群）の処置に使用するためのＢＹＬ７１９（アルペリシブ）

Assigned to Centre National de la Recherche Scientifique CNRS · Expires 2022-04-11 · 4y expired

What this patent protects

Patent listed against Piqray.

Drugs covered by this patent

Patent Metadata

Patent number
JP7051693B2
Jurisdiction
JP
Classification
—
Expires
2022-04-11
Drug substance claim
No
Drug product claim
No
Assignee
Centre National de la Recherche Scientifique CNRS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.